Table 2.
Dose (cGy) | Stage | Surgery | HER2 | Pretreatment Lymphocytes |
Posttreatment Lymphocytes |
Δ Lymphocytes |
---|---|---|---|---|---|---|
5,400 | 1 | M | I | 0.7 | 0.34 | −0.36 |
6,000 | 2 | M | N | 1.07 | 0.84 | −0.23 |
6,000 | 2 | L | N | 1.22 | 0.68 | −0.54 |
6,000 | 2 | M | N | 0.85 | 0.62 | −0.23 |
6,040 | 3 | M | P | 1 | 0.57 | −0.43 |
6,040 | 3 | M | N | 0.83 | 0.25 | −0.58 |
6,040 | 3 | M | N | 1.24 | 0.79 | −0.45 |
6,300 | 2 | L | P | 0.7 | 0.5 | −0.2 |
6,400 | 1 | L | N | 1.06 | 0.8 | −0.26 |
6,440 | 2 | L | P | 1 | 1.1 | 0.1 |
6,520 | 3 | L | N | 1.1 | 0.5 | −0.6 |
6,520 | 3 | M | I | 0.7 | 0.5 | −0.2 |
6,640 | 1 | L | N | 1.04 | 0.58 | −0.46 |
6,640 | 3 | M | N | 1.25 | 0.39 | −0.86 |
I = indeterminant; L = lumpectomy; M = mastectomy; N = negative; P = positive.